The European benchmark rose 0.33 per cent on the day. Franco-Italian eyewear group EssilorLuxottica shares jumped 6.9 per ...

European stocks closed on a positive note with financials and defense stocks leading, despite a significant drop in Danish ...

The obesity drug bubble has been leaking air for about a year. On Tuesday morning, it appears to have definitively burst, at ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

The biggest fallers on the FTSE 100 were Croda International, down 301p at 2,598p; Rentokil Initial, down 12.9p at 348.1p; ...

Torrent Pharmaceuticals is preparing to introduce both oral and injectable versions of Semaglutide, a blockbuster diabetes ...

Facing a $70 billion market loss, Novo Nordisk appointed Maziar Mike Doustdar as its new CEO to navigate intensifying ...

Wall Street chugged mostly higher in premarket trading as Chinese and U.S. officials begin a second day of trade talks and the Federal Reserve kicks off its two-day meeting to make a decision on ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

Seeking Alpha's roundup of statements, announcements and remarks that could impact markets, sectors or individual stocks.

The maker of GLP-1 drugs Ozempic and Wegovy cut sales grown from 13%-21% down to 8%-14% for the year. That's about half, on the higher end, of the 26% growth seen in 2024. Outgoing CEO Lars Jøregensen ...